Bladder Cancer:
Immunotherapy has shown efficacy, particularly in advanced or metastatic cases.
Brain Cancer:
While challenging, immunotherapy research offers hope for targeting glioblastomas and other brain tumors.
Breast Cancer:
Certain types of breast cancer, such as triple-negative, may respond well to immunotherapy.
Cervical Cancer:
Immunotherapy, including checkpoint inhibitors, is being investigated as a potential treatment for advanced cervical cancer.
Colorectal Cancer:
Medical experts are increasingly using immunotherapy in colorectal cancer. It is particularly helpful in cases with specific genetic mutations.
Esophageal Cancer:
Doctors are exploring immunotherapy as a treatment option for esophageal cancer, especially in combination with other therapies.
Head and Neck Cancer:
Immunotherapy, including checkpoint inhibitors, has shown promise in treating specific head and neck cancers.
Kidney Cancer:
Immunotherapy has become a standard treatment for advanced or metastatic kidney cancer.
Lung Cancer:
Immunotherapy, especially with drugs like pembrolizumab and nivolumab, has shown significant efficacy in advanced non-small cell lung cancer (NSCLC).
Leukemia:
Immunotherapy, such as CAR-T cell therapy, offers new hope for some types of leukemia, particularly in relapsed or refractory cases.
Liver Cancer:
Cancer specialists are studying immunotherapy as a potential treatment for liver cancer, particularly in combination with other therapies.
Lymphoma:
Immunotherapy, including monoclonal antibodies and CAR-T cell therapy, has revolutionized treatment options for certain types of lymphoma.